These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1758885)

  • 1. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
    Moon JB; Howe WJ
    Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo ligand design to an ensemble of protein structures.
    Todorov NP; Buenemann CL; Alberts IL
    Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites.
    Laurie AT; Jackson RM
    Bioinformatics; 2005 May; 21(9):1908-16. PubMed ID: 15701681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design.
    Zauhar RJ; Moyna G; Tian L; Li Z; Welsh WJ
    J Med Chem; 2003 Dec; 46(26):5674-90. PubMed ID: 14667221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLEXS: a method for fast flexible ligand superposition.
    Lemmen C; Lengauer T; Klebe G
    J Med Chem; 1998 Nov; 41(23):4502-20. PubMed ID: 9804690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEA3D: a computer-aided ligand design for structure-based drug design.
    Douguet D; Munier-Lehmann H; Labesse G; Pochet S
    J Med Chem; 2005 Apr; 48(7):2457-68. PubMed ID: 15801836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling side-chains using molecular dynamics improve recognition of binding region in CAPRI targets.
    Camacho CJ
    Proteins; 2005 Aug; 60(2):245-51. PubMed ID: 15981253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational automatic search method for stable docking models of protein and ligand.
    Mizutani MY; Tomioka N; Itai A
    J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DynaDock: A new molecular dynamics-based algorithm for protein-peptide docking including receptor flexibility.
    Antes I
    Proteins; 2010 Apr; 78(5):1084-104. PubMed ID: 20017216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo protein design. I. In search of stability and specificity.
    Koehl P; Levitt M
    J Mol Biol; 1999 Nov; 293(5):1161-81. PubMed ID: 10547293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor.
    Laakkonen LJ; Guarnieri F; Perlman JH; Gershengorn MC; Osman R
    Biochemistry; 1996 Jun; 35(24):7651-63. PubMed ID: 8672466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor flexibility in de novo ligand design and docking.
    Alberts IL; Todorov NP; Dean PM
    J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
    Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
    J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEARLS: program for energetic analysis of receptor-ligand system.
    Han LY; Lin HH; Li ZR; Zheng CJ; Cao ZW; Xie B; Chen YZ
    J Chem Inf Model; 2006; 46(1):445-50. PubMed ID: 16426079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.